Erythropoietin to Improve Critical Care Patient Outcomes

NCT05080049 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

42

Enrollment

OTHER_GOV

Sponsor class

Conditions

Anemia
Intensive Care

Interventions

DRUG: Erythropoietin
DRUG: Placebo

Sponsor

University Hospital, Angers